These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1125731)
61. A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure. Rao CR J Int Med Res; 1982; 10(5):357-60. PubMed ID: 6754508 [TBL] [Abstract][Full Text] [Related]
62. Bioequivalence of a slow-release potassium tablet and a liquid potassium supplement. Lowance DC; Murad F; Darrow WR; Bonus L Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):204-8. PubMed ID: 7095919 [TBL] [Abstract][Full Text] [Related]
64. Patient preference study of two potassium chloride supplements: Slow-K and Micro-K 10 Extencaps. Zukof M Clin Ther; 1991; 13(3):425-9. PubMed ID: 1954643 [TBL] [Abstract][Full Text] [Related]
65. Potassium supplements during treatment of glaucoma with acetazolamide. Critchlow AS; Freeborn SN; Roddie RA Br Med J (Clin Res Ed); 1984 Jul; 289(6436):21. PubMed ID: 6428649 [No Abstract] [Full Text] [Related]
66. Microencapsulation of potassium chloride with mastic. Georgarakis M; Gröning R; Henzler P Pharmazie; 1987 Jul; 42(7):455-6. PubMed ID: 3671470 [TBL] [Abstract][Full Text] [Related]
67. Side-effects of potassium chloride in products with different dissolution rates. Graffner C; Sjögren J Acta Pharm Suec; 1971 Mar; 8(1):19-26. PubMed ID: 5575870 [No Abstract] [Full Text] [Related]
68. Evaluation of patients' preference of two potassium chloride supplements: Slow-K and K-Dur. Pietro DA; Davidson L Clin Ther; 1990; 12(5):431-5. PubMed ID: 2268865 [TBL] [Abstract][Full Text] [Related]
71. Short-term follow-up study of wax matrix potassium chloride in relation to gastrointestinal bleeding. Aselton PJ; Jick H Lancet; 1983 Jan; 1(8317):184. PubMed ID: 6130224 [No Abstract] [Full Text] [Related]
72. Epidural injection of potassium hydrochloride. Vercauteren M; Saldien V Acta Anaesthesiol Scand; 1996 Apr; 40(4):505. PubMed ID: 8738699 [No Abstract] [Full Text] [Related]
73. Bioavailability of potassium from controlled-release tablets with and without water loading. Bechgaard H; Shephard NW Eur J Clin Pharmacol; 1981; 21(2):143-7. PubMed ID: 7341281 [TBL] [Abstract][Full Text] [Related]
74. Pill-induced esophageal injury. Case reports and review of the medical literature. Kikendall JW; Friedman AC; Oyewole MA; Fleischer D; Johnson LF Dig Dis Sci; 1983 Feb; 28(2):174-82. PubMed ID: 6825537 [TBL] [Abstract][Full Text] [Related]
75. Irritative properties of two clinical potassium chloride formulations on duodenal mucosa of the cat and esophageal mucosa of the opossum. Alphin RS; O'Dell SW; Sancilio LF; Ward JW Dig Dis Sci; 1984 Jun; 29(6):508-12. PubMed ID: 6723482 [TBL] [Abstract][Full Text] [Related]
76. Benign stricture of the oesophagus: role of non-steroidal anti-inflammatory drugs. Wilkins WE; Ridley MG; Pozniak AL Gut; 1984 May; 25(5):478-80. PubMed ID: 6714790 [TBL] [Abstract][Full Text] [Related]
77. Effect of left atrial size on the oesophageal transit of capsules. Channer KS; Bell J; Virjee JP Br Heart J; 1984 Aug; 52(2):223-7. PubMed ID: 6234911 [TBL] [Abstract][Full Text] [Related]